Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Multiple Sclerosis

  Free Subscription

Articles published in Immunol Cell Biol

Retrieve available abstracts of 6 articles:
HTML format
Text format

Single Articles

    June 2019
  1. RICHMAN SA, Hunter CA
    beta-synuclein at the "synapse" of encephalitis and neurodegeneration in multiple sclerosis?
    Immunol Cell Biol. 2019 Jun 12. doi: 10.1111/imcb.12270.
    PubMed     Text format     Abstract available

    March 2018
  2. IACOBAEUS E, Douagi I, Jitschin R, Marcusson-Stahl M, et al
    Phenotypic and functional alterations of myeloid derived suppressor cells during multiple sclerosis disease course.
    Immunol Cell Biol. 2018 Mar 22. doi: 10.1111/imcb.12042.
    PubMed     Text format     Abstract available

    January 2018
  3. AJAMI B, Steinman L
    Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?
    Immunol Cell Biol. 2018 Jan 20. doi: 10.1111/imcb.12004.
    PubMed     Text format    

    October 2017
  4. GJELSTRUP MC, Stilund M, Petersen T, Moller HJ, et al
    Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.
    Immunol Cell Biol. 2017 Oct 19. doi: 10.1111/imcb.1025.
    PubMed     Text format     Abstract available

    March 2017
  5. CHULUUNDORJ D, Harding SA, Abernethy D, La Flamme AC, et al
    Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
    Immunol Cell Biol. 2017;95:297-305.
    PubMed     Text format     Abstract available

    February 2017
  6. ZANDEE SE, O'Connor RA, Mair I, Leech MD, et al
    IL-10-producing, ST2-expressing Foxp3+ T cells in multiple sclerosis brain lesions.
    Immunol Cell Biol. 2017 Feb 7. doi: 10.1038/icb.2017.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.